() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: POCM

Pocml 4 Inc. Announces the Signing of Two Cannabis Concentrate Program Agreements by MediPharm Labs Inc.

POCML 4 Inc. (TSXV: POCM) (“POCML”) is pleased to announce that MediPharm Labs Inc. (“MediPharm”) has entered into Cannabis Concentrate Program Agreements with each of James E. Wagner Cultivation Corporation (TSXV:JWCA) ("JWC") and Bonify ("Bonify"), collectively (the “Companies”). Pursuant to the agreements, the Companies have entered into commercial arrangements whereby each of JWC and Bonify will provide MediPharm with dried cannabis to use for the purposes of creating purity-assured cannabis oil (the "Program").
Read more

POCML 4 Inc. Executes Definitive Agreement With MediPharm Labs Inc.

POCML 4 Inc. (TSXV:POCM) (“POCML”) is pleased to announce that it has entered into a definitive agreement with MediPharm Labs Inc. (“MediPharm”). MediPharm is a medicinal cannabis company specializing in the pharmaceutical production of oil products as a licensed producer by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), and is the first company in Canada to become a licensed producer for cannabis oil production without first receiving a cannabis cultivation licence.
Read more